These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 33448035)

  • 1. Nanoparticle-Mediated Delivery of Inhaled Immunotherapeutics for Treating Lung Metastasis.
    Jin Q; Zhu W; Zhu J; Zhu J; Shen J; Liu Z; Yang Y; Chen Q
    Adv Mater; 2021 Feb; 33(7):e2007557. PubMed ID: 33448035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A metal-organic nanoframework for efficient colorectal cancer immunotherapy by the cGAS-STING pathway activation and immune checkpoint blockade.
    Zhang X; Tian H; Chen Y; Liang B; Nice EC; Huang C; Xie N; Zheng S
    J Nanobiotechnology; 2024 Sep; 22(1):592. PubMed ID: 39343911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local and Targeted Delivery of Immune Checkpoint Blockade Therapeutics.
    Han X; Li H; Zhou D; Chen Z; Gu Z
    Acc Chem Res; 2020 Nov; 53(11):2521-2533. PubMed ID: 33073988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of a core-shell microneedle system to achieve targeted co-delivery of checkpoint inhibitors for melanoma immunotherapy.
    Yang P; Lu C; Qin W; Chen M; Quan G; Liu H; Wang L; Bai X; Pan X; Wu C
    Acta Biomater; 2020 Mar; 104():147-157. PubMed ID: 31904558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic engineering cellular vesicles expressing CD64 as checkpoint antibody carrier for cancer immunotherapy.
    Li L; Miao Q; Meng F; Li B; Xue T; Fang T; Zhang Z; Zhang J; Ye X; Kang Y; Zhang X; Chen Q; Liang X; Chen H; Zhang X
    Theranostics; 2021; 11(12):6033-6043. PubMed ID: 33897897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical development of the TLR9 agonist DV281 as an inhaled aerosolized immunotherapeutic for lung cancer: Pharmacological profile in mice, non-human primates, and human primary cells.
    Kell SA; Kachura MA; Renn A; Traquina P; Coffman RL; Campbell JD
    Int Immunopharmacol; 2019 Jan; 66():296-308. PubMed ID: 30502651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aerosolized immunotherapeutic nanoparticle inhalation potentiates PD-L1 blockade for locally advanced lung cancer.
    Liu Y; Crowe WN; Wang L; Petty WJ; Habib AA; Zhao D
    Nano Res; 2023 Apr; 16(4):5300-5310. PubMed ID: 37228440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Small Molecule Antagonist of PD-1/PD-L1 Interactions Acts as an Immune Checkpoint Inhibitor for NSCLC and Melanoma Immunotherapy.
    Wang Y; Gu T; Tian X; Li W; Zhao R; Yang W; Gao Q; Li T; Shim JH; Zhang C; Liu K; Lee MH
    Front Immunol; 2021; 12():654463. PubMed ID: 34054817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Programmed cell death ligand-1: A dynamic immune checkpoint in cancer therapy.
    Kalim M; Iqbal Khan MS; Zhan J
    Chem Biol Drug Des; 2020 Jun; 95(6):552-566. PubMed ID: 32166894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis.
    Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H
    JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of PD-1 in complex with an antibody-drug tislelizumab used in tumor immune checkpoint therapy.
    Lee SH; Lee HT; Lim H; Kim Y; Park UB; Heo YS
    Biochem Biophys Res Commun; 2020 Jun; 527(1):226-231. PubMed ID: 32446372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose carboplatin reprograms tumor immune microenvironment through STING signaling pathway and synergizes with PD-1 inhibitors in lung cancer.
    Zhou L; Xu Q; Huang L; Jin J; Zuo X; Zhang Q; Ye L; Zhu S; Zhan P; Ren J; Lv T; Song Y
    Cancer Lett; 2021 Mar; 500():163-171. PubMed ID: 33278498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lovastatin/SN38 co-loaded liposomes amplified ICB therapeutic effect via remodeling the immunologically-cold colon tumor and synergized stimulation of cGAS-STING pathway.
    Yang Y; Qi J; Hu J; Zhou Y; Zheng J; Deng W; Inam M; Guo J; Xie Y; Li Y; Xu C; Deng W; Chen W
    Cancer Lett; 2024 Apr; 588():216765. PubMed ID: 38408604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poxvirus-based active immunotherapy synergizes with CTLA-4 blockade to increase survival in a murine tumor model by improving the magnitude and quality of cytotoxic T cells.
    Foy SP; Mandl SJ; dela Cruz T; Cote JJ; Gordon EJ; Trent E; Delcayre A; Breitmeyer J; Franzusoff A; Rountree RB
    Cancer Immunol Immunother; 2016 May; 65(5):537-49. PubMed ID: 26961085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomineralized MnO
    Deng Z; Xi M; Zhang C; Wu X; Li Q; Wang C; Fang H; Sun G; Zhang Y; Yang G; Liu Z
    ACS Nano; 2023 Mar; 17(5):4495-4506. PubMed ID: 36848115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PDL1-positive exosomes suppress antitumor immunity by inducing tumor-specific CD8
    Chen J; Song Y; Miao F; Chen G; Zhu Y; Wu N; Pang L; Chen Z; Chen X
    Cancer Sci; 2021 Sep; 112(9):3437-3454. PubMed ID: 34152672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docetaxel in chitosan-based nanocapsules conjugated with an anti-Tn antigen mouse/human chimeric antibody as a promising targeting strategy of lung tumors.
    Castro A; Berois N; Malanga A; Ortega C; Oppezzo P; Pristch O; Mombrú AW; Osinaga E; Pardo H
    Int J Biol Macromol; 2021 Jul; 182():806-814. PubMed ID: 33857513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of Response to Immune Checkpoint Inhibitor Monotherapy or 
Combination with Chemotherapy for Patients with Advanced Non-small Cell Lung Cancer and High PD-L1 Expression].
    Li H; Qin N; Yu M; Ma L; Wu Y; Zhang H; Zhang X; Li X; Wang J
    Zhongguo Fei Ai Za Zhi; 2021 Mar; 24(3):161-166. PubMed ID: 33819965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhalable nanoparticles with enhanced cuproptosis and cGAS-STING activation for synergistic lung metastasis immunotherapy.
    Yan C; Lv H; Feng Y; Li Y; Zhao Z
    Acta Pharm Sin B; 2024 Aug; 14(8):3697-3710. PubMed ID: 39220876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TCR Repertoire Diversity of Peripheral PD-1
    Han J; Duan J; Bai H; Wang Y; Wan R; Wang X; Chen S; Tian Y; Wang D; Fei K; Yao Z; Wang S; Lu Z; Wang Z; Wang J
    Cancer Immunol Res; 2020 Jan; 8(1):146-154. PubMed ID: 31719056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.